HOME | Alphawatch

top of page

Stock Exchange

Commerical Aerospace Ideas and Why It is an Interesting Mid- and Long-Term Investing Opportunity

Commerical Aerospace Ideas and Why It is an Interesting Mid- and Long-Term Investing Opportunity

Commerical Aerospace Ideas and Why It is an Interesting Mid- and Long-Term Investing Opportunity

Jonathan Poyer

4 hours ago4 min read

Novartis to Acquire Regulus Therapeutics for $1.7B

Novartis to Acquire Regulus Therapeutics for $1.7B

Novartis to Acquire Regulus Therapeutics for $1.7B

Jonathan Poyer

Apr 301 min read

Following the Trend Following Trend...

Following the Trend Following Trend...

Following the Trend Following Trend...

Jonathan Poyer

Apr 252 min read

The Doctor is IN | April 2025

The Doctor is IN | April 2025

The Doctor is IN | April 2025

Jonathan Poyer

Apr 221 min read

Merck's Announcement of Successful Phase 3 Trial of Subcutaneous Keytruda Progresses Towards FDA Submission

Merck's Announcement of Successful Phase 3 Trial of Subcutaneous Keytruda Progresses Towards FDA Submission

Merck's Announcement of Successful Phase 3 Trial of Subcutaneous Keytruda Progresses Towards FDA Submission

Jonathan Poyer

Mar 312 min read

AbbVie and the Influence of AI on Research

AbbVie and the Influence of AI on Research

AbbVie and the Influence of AI on Research

Jonathan Poyer

Mar 241 min read

March Shows Some Life for Biotech M&A With Over $1.7B in Deals.

March Shows Some Life for Biotech M&A With Over $1.7B in Deals.

March Shows Some Life for Biotech M&A With Over $1.7B in Deals.

Jonathan Poyer

Mar 211 min read

The Doctor is IN | March 2025

The Doctor is IN | March 2025

The Doctor is IN | March 2025

Jonathan Poyer

Mar 211 min read

Patient Death Associated with Sarepta Drug - Stock Plummets

Patient Death Associated with Sarepta Drug - Stock Plummets

Patient Death Associated with Sarepta Drug - Stock Plummets

Jonathan Poyer

Mar 211 min read

March 2025 Riffin' on Real Estate

March 2025 Riffin' on Real Estate

March 2025 Riffin' on Real Estate

Jonathan Poyer

Mar 131 min read

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Jonathan Poyer

Mar 62 min read

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

Jonathan Poyer

Mar 61 min read

bottom of page